KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Account Payables (2016 - 2026)

Amgen has reported Change in Account Payables over the past 18 years, most recently at $571.0 million for Q1 2026.

  • For Q1 2026, Change in Account Payables rose 14.89% year-over-year to $571.0 million; the TTM value through Mar 2026 reached $502.0 million, down 36.13%, while the annual FY2025 figure was $428.0 million, 37.18% up from the prior year.
  • Change in Account Payables for Q1 2026 was $571.0 million at Amgen, up from -$484.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $643.0 million in Q2 2024 and troughed at -$484.0 million in Q4 2025.
  • A 5-year average of $62.5 million and a median of -$44.0 million in 2022 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: plummeted 702.38% in 2023 and later surged 2060.87% in 2025.
  • Year by year, Change in Account Payables stood at $296.0 million in 2022, then plummeted by 163.18% to -$187.0 million in 2023, then decreased by 24.06% to -$232.0 million in 2024, then crashed by 108.62% to -$484.0 million in 2025, then soared by 217.98% to $571.0 million in 2026.
  • Business Quant data shows Change in Account Payables for AMGN at $571.0 million in Q1 2026, -$484.0 million in Q4 2025, and -$174.0 million in Q3 2025.